From the MDS Beacon...
Thalidomide-Trisenox Combination May Be Effective And Safe In MDS Patients
by Jessica Langholtz and Maike Haehle
Results from a small study conducted in China suggest that combination therapy with thalidomide and Trisenox is an effective and safe treatment for myelodysplastic syndromes.
Patients who received the combination therapy experienced higher response rates and longer survival times than patients who received best supportive care.
For the rest, see the article at MDS Beacon.